We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+12.54%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.02%
AUM
$8.03B
AUM Growth
+$505M
Cap. Flow
-$223M
Cap. Flow %
-2.78%
Top 10 Hldgs %
12.3%
Holding
1,464
New
99
Increased
306
Reduced
315
Closed
129

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$52.5M
2
DIS icon
Walt Disney
DIS
+$50.9M
3
O icon
Realty Income
O
+$46M
4
QCOM icon
Qualcomm
QCOM
+$43.6M
5
CHD icon
Church & Dwight Co
CHD
+$35.2M

Top Sells

Rank Stock Value
1
KO icon
Coca-Cola
KO
+$58.8M
2
TGT icon
Target
TGT
+$46.7M
3
EMN icon
Eastman Chemical
EMN
+$43.1M
4
AGN
Allergan plc
AGN
+$41.1M
5
MRO
Marathon Oil Corporation
MRO
+$41.1M

Sector Composition

Rank Sector Weight
1 Financials 24.51%
2 Technology 12.33%
3 Healthcare 11.26%
4 Consumer Discretionary 11.18%
5 Industrials 10.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LIVE icon
1276
Live Ventures
LIVE
$29M
$105K ﹤0.01%
13,702
CRBP icon
1277
Corbus Pharmaceuticals
CRBP
$174M
$103K ﹤0.01%
493
BLPH
1278
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$103K ﹤0.01%
10,533
-1,667
-14% -$18.4K
KA
1279
DELISTED
Kineta, Inc. Common Stock
KA
$101K ﹤0.01%
571
KONA
1280
DELISTED
Kona Grill, Inc.
KONA
$100K ﹤0.01%
110,200
SER icon
1281
Serina Therapeutics
SER
$32.1M
$97K ﹤0.01%
684
PFIN
1282
DELISTED
P&F Industries
PFIN
$95K ﹤0.01%
11,688
OCC icon
1283
Optical Cable Corp
OCC
$142M
$94K ﹤0.01%
20,100
ATOS icon
1284
Atossa Therapeutics
ATOS
$23M
$92K ﹤0.01%
+1,747
New +$50.9K
LTRX icon
1285
Lantronix
LTRX
$272M
$89K ﹤0.01%
29,400
-24,100
-45% -$69.8K
PLX icon
1286
Protalix BioTherapeutics
PLX
$191M
$89K ﹤0.01%
20,259
AMTX icon
1287
Aemetis
AMTX
$114M
$86K ﹤0.01%
103,239
PRHI
1288
Presurance Holdings
PRHI
$19.2M
$86K ﹤0.01%
2,714
ALTO icon
1289
Alto Ingredients
ALTO
$410M
$85K ﹤0.01%
86,900
APVO icon
1290
Aptevo Therapeutics
APVO
$5.1M
0
CCLD icon
1291
CareCloud
CCLD
$110M
$84K ﹤0.01%
19,000
-9,000
-32% -$39.7K
OMED
1292
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$84K ﹤0.01%
80,900
-50,000
-38% -$40.7K
QUIK icon
1293
QuickLogic
QUIK
$260M
$82K ﹤0.01%
9,629
TCON
1294
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$82K ﹤0.01%
+300
New +$65K
STKS icon
1295
The ONE Group
STKS
$55.2M
$81K ﹤0.01%
27,400
ITI
1296
DELISTED
Iteris, Inc.
ITI
$79K ﹤0.01%
18,932
-228,100
-92% -$941K
CRVO icon
1297
CervoMed
CRVO
$25.9M
$78K ﹤0.01%
+281
New +$67.4K
KSPN
1298
DELISTED
Kaspien Holdings Inc. Common Stock
KSPN
$74K ﹤0.01%
8,780
MICR
1299
DELISTED
Micron Solutions, Inc.
MICR
$74K ﹤0.01%
26,425
AWX icon
1300
Avalon Holdings
AWX
$9.83M
$71K ﹤0.01%
27,375

Similar funds

Bridgeway Capital Management's Q1 2019 Portfolio in Review

As of Q1 2019, Bridgeway Capital Management held 1,464 positions worth $8.03B, up 6.7% from $7.53B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Bridgeway Capital Management's Q1 2019 filing shows 99 new, 306 increased, 315 reduced and 129 closed positions. Its largest new stake was Realty Income: 694,072 shares worth $49.5M. The largest sale was Coca-Cola, an estimated $58.8M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 24% a quarter earlier, followed by Technology and Healthcare.

  • Bridgeway Capital Management's largest Q1 2019 buy was Realty Income: 694,072 shares worth $49.5M.
  • Bridgeway Capital Management added most to Microsoft in Q1 2019, an estimated $52.5M increase.
  • Bridgeway Capital Management's biggest Q1 2019 reduction was Coca-Cola, cutting an estimated $58.8M.
  • Bridgeway Capital Management fully exited Target in Q1 2019, selling an estimated $46.7M.
  • Bridgeway Capital Management's ten largest holdings make up 12% of its $8.03B portfolio in Q1 2019.
  • Bridgeway Capital Management opened 99 new positions and closed 129 in Q1 2019.
  • Bridgeway Capital Management's portfolio value rose 6.7% quarter-over-quarter to $8.03B.

Based on Bridgeway Capital Management's 13F filing for Q1 2019, filed 15 May 2019.